Behandlingen skal opretholdes i tilfælde af stabil sygdom, dvs. statisk, delvis eller komplet tumorrespons, forudsat at midlet tåles tilstrækkelig godt.
Treatment should be maintained in the case of stable disease, i. e. static, partial or complete tumour response, provided that the product is sufficiently well tolerated.